Low plasma granulocyte-macrophage colony stimulating factor is an indicator of poor prognosis in sepsis

Intensive Care Medicine

Volumn 28, Issue 7, 2002, Pages 981-984

  Perry, Sara E ^a   Mostafa, Sobhy M ^b   Wenstone, Richard ^b   McLaughlin, Paul J ^a  

^a Duncan Building ^*  (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Compensatory anti inflammatory response syndrome (CARS); Granulocyte macrophage colony stimulating factor (GM CSF); Monocyte; Prognosis; Sepsis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SEPSIS; SURVIVAL; APACHE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED KINGDOM;

ADULT; APACHE; CASE-CONTROL STUDIES; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GREAT BRITAIN; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; SEPSIS; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0036020313     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1335-1     Document Type: Article

References (14)

1. Immunomodulatory therapies in sepsis
2. Sepsis syndromes: Understanding the role of innate and acquired immunity
3. Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy
4. Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors
5. Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass and severe sepsis
6. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo
7. The ACCP-SCCM consensus conference on sepsis and organ failure
8. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy regulates the expression and secretion of monocyte tumor necrosis factor (TNF) and TNF receptors p55 and p75
9. The beneficial effects of immunostimulation in posttraumatic sepsis
10. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia
11. Identification of the soluble granulocyte-macrophage colony stimulating factor receptor protein in vivo
12. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment
13. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Comparisons and potential for use in the treatment of infections in non-neutropenic patients
14. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: Relation to disease severity, multiple organ dysfunction and mortality